Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

Phase II open-label clinical trial evaluating efficacy of romiplostim added to standard of care for children and young adults with treatment naive and relapsed or refractory severe aplastic anemia

Pediatrics Pediatric Subjects Adult Subjects

Principal investigator

Anjali Sharathkumar

Pediatrics

View other research studies by Anjali Sharathkumar

Participate in this trial

Are you interested in enrolling in this study? Learn more here.

I'm Interested In Participating

Details

IRB Number

202308492

Study Status

Open

Currently Recruiting

Yes

Study Type

Interventional

Cancer Study

Compensation Available

Yes